HIV Clinical Trials

Birmingham : University of Alabama at Birmingham

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Birmingham : UAB Dental School

Longitudinal Study of Dental Implant Therapy in HIV- Positive Patients

Birmingham : The University of Alabama at Birmingham

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Phoenix : Southwest Center for HIV/AIDS

Are You Living with HIV and Have Type 2 Diabetes?

Phoenix : Southwest Center for HIV/AIDS

Help Find More Efficient Ways to Test for HIV

View More »

Phoenix : Phoenix Children's Hospital

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens

Phoenix : Spectrum Medical Group

Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Phoenix : Spectrum Medical Group

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Phoenix : Spectrum Medical Group

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Phoenix : Spectrum Medical Group

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Phoenix : Spectrum Medical Group

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Los Angeles : Charles R. Drew University - Clinical Research Center

Testosterone Replacement and Physical Function in HIV-Associated Weight Loss.

View More »

Beverly Hills : AHF Research Center

A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System

Hayward : Kaiser Permanente

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Hayward : Kaiser Permanente

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Long Beach : Long Beach Education and Research Consultants (LBERC)

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Long Beach : Living Hope Clinical Foundation

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Los Angeles : UCLA Care Center

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Los Angeles : LAC+USC MCA Clinic

Etravirine Pharmacokinetics and HIV Viral Load in Breast Milk and Plasma

Los Angeles : Anthony Mills MD, Inc

Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Los Angeles : Peter J Ruane, MD, Inc

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Los Angeles : Anthony Mills MD Inc

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Los Angeles : UCLA Center for AIDS Research and Education

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

Los Angeles : Anthony Mills MD Inc

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Los Angeles : Peter J Ruane MD Inc.

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Los Angeles : AIDS Healthcare Foundation

Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients

Los Angeles : Anthony Mills, MD Internal Medicine

Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients

Los Angeles : University of Southern California

Strategic Timing of Antiretroviral Treatment

Los Angeles : VA Greater Los Angeles Healthcare System

Strategic Timing of Antiretroviral Treatment

Los Angeles : UCLA CARE-4-Families (LABAC CRS)

Strategic Timing of Antiretroviral Treatment

Los Angeles : Anthony Mills MD Inc

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Los Angeles : Kaiser Permanente Los Angeles

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Los Angeles : Peter J. Ruane, Inc.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Los Angeles : Kaiser Permanente - Los Angeles Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Los Angeles : Anthony Mills MD Inc

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Los Angeles : Peter J. Ruane, MD, Inc.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Newport Beach : Orange Coast Medical Group

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Newport Beach : Orange Coast Medical Group

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

Oakland : East Bay AIDS Center Medical Group

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Oakland : East Bay AIDS Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Sacramento : Kaiser Permanente Medical Group

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Sacramento : Kaiser Permanente - Sacramento

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

San Diego : La Playa Medical Group and Clinical Research

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

San Diego : La Playa Medical Group and Clinical Research

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

San Diego : UCSD Antiviral Research Center

Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals

San Diego : UCSD Mother-Child-Adolescent Program

Strategic Timing of Antiretroviral Treatment

San Diego : Naval Medical Center San Diego

Strategic Timing of Antiretroviral Treatment

San Diego : La Playa Medical Group and Clinical Research

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

San Diego : La Playa Medical Group and Clinical Research

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

San Francisco : Quest Clinical Research

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

San Francisco : San Francisco VA Medical Center

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

San Francisco : Quest Clinical Research

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

San Francisco : Metropolis Medical

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

San Francisco : Kaiser Permanente Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

San Francisco : San Francisco General Hospital

Using Heavy Water to Study Cell Dynamics in Parkinson's Disease

Torrance : Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Denver : University of Colorado Health Sciences Center

A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication

Denver : Apex Research LLC

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Denver : Denver Infectious Disease Consultants, PLLC

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Denver : Apex Research, LLC

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Denver : APEX Research LLC

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

New Haven : Yale University School of Medicine

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

New Haven : Yale University School of Medicine

Strategic Timing of Antiretroviral Treatment

New Haven : Yale University School of Medicine

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Norwalk : Circle CARE Center, LLC

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Norwalk : Circle CARE Center, LLC

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

Washington : Georgetown University

Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients

Washington : Whitman Walker Clinic

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Washington : Dupont Circle Physicians Group

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Washington : Dupont Circle Physician's Group

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Washington : Whitman-Walker Health

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

View More »

Washington : George Washington University Medical Faculty Associates

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Washington : Children'S National Medical Center

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Washington : Whitman-Walker Clinic

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Washington : Washington DC VA Medical Center

Strategic Timing of Antiretroviral Treatment

Washington : George Washington University Medical Center

Strategic Timing of Antiretroviral Treatment

Washington : Georgetown University

Strategic Timing of Antiretroviral Treatment

Washington : Whitman Walker Clinic

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Washington : Capital Medical Associates, P.C.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Washington : Dupont Circle Physicians Group, P.C.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Washington : Whitman-Walker Health

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Washington : Dupont Circle Physicians Group

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Washington : Capital Medical Associates, PC

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Washington : Medical Faculty Associates, Inc.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Daytona Beach :

A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women

Fort Lauderdale : Gary J. Richmond, MD PA

Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Fort Lauderdale : Gary J. Richmond,M.D.,P.A.

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Fort Lauderdale : Gary J. Richmond,M.D., P.A.

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Fort Lauderdale : Gary J. Richmond,M.D.,P.A.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

View More »

Fort Lauderdale : TheraFirst Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Fort Lauderdale : Gary Richmond, MD, PA, Inc.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Fort Pierce : Midway Immunology and Research Center

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Fort Pierce : Midway Immunology and Research Center

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Fort Pierce : Midway Immunology and Research Center

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Fort Pierce : Midway Immunology and Research Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Fort Pierce : Midway Immunology & Research Center, LLC

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Jacksonville : University of Florida, Jacksonville

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Jacksonville : University of Florida, Jacksonville

Strategic Timing of Antiretroviral Treatment

Jacksonville : University of Florida Health Services Center

Strategic Timing of Antiretroviral Treatment

Miami :

A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women

Miami : AHF - Kinder Medical Group

Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Miami : The Kinder Medical Group

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Miami : University of Miami

Strategic Timing of Antiretroviral Treatment

Miami Beach : Wohlfeiler, Piperato and Associates, LLC

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Miami Beach : Wohlfeiler, Piperato and Associates, LLC

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Miami Beach : AIDS Healthcare Foundation

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Orlando : Orlando Immunology Center

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Orlando : IDOCF/ Value Health MD, LLC

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Orlando : Orlando Immunology Center

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Orlando : Orlando Immunology Center

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

Orlando : Orlando Immunology Center

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Orlando : Idocf/Valuhealthmd, Llc

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Orlando : IDOCF/ValuhealthMD

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Orlando : Orlando Immunology Center

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Orlando : Florida Department of Health in Orange County/Hug Me

Strategic Timing of Antiretroviral Treatment

Orlando : Orlando Immunology Center

Strategic Timing of Antiretroviral Treatment

Orlando : Orlando Immunology Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Orlando : Orlando Immunology Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Orlando : Idocf/Valuhealthmd

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Orlando : IDOCF/ValuHealthMD, LLC

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Pensacola : Infectious Diseases Associates NW FL, PA

Strategic Timing of Antiretroviral Treatment

Pensacola : Infectious Diseases Associates

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Pensacola : Infectious Diseases Associates of NW FL

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Port St. Lucie :

A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women

Safety Harbor : AHF Health Positive - Tampa Bay

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Safety Harbor : Barry M. Rodwick, M. D.

Pilot Assessment of Lopinavir/Ritonavir and Maraviroc

Tampa : University of South Florida - Department of Pediatrics

Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Tampa : Infectious Disease Research Institute Inc.

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Tampa : University of South Florida - Department of Pediatrics

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Tampa : St. Joseph's Hospital Comprehensive Research Institute

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Tampa : USF Health - HIV Clinical Research Unit

Strategic Timing of Antiretroviral Treatment

Tampa : Infectious Disease Research Institute Inc.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Tampa : The University of South Florida

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Tampa : St. Joseph's Comprenhensive Research Inisitute

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Tampa : Infectious Disease Research Institute Inc.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Vero Beach : Treasure Coast Infectious Disease Consultants

Strategic Timing of Antiretroviral Treatment

Vero Beach : AIDS Research and Treatment Center of the Treasure Coast

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Vero Beach : AIDS Research and Treatment Center of the Treasure Coast

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

West Palm Beach :

A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women

Atlanta : AIDS Research Consortium of Atlanta

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Atlanta : Atlanta ID Group, PC

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Atlanta : AIDS Research Consortium of Atlanta

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Atlanta : Emory HIV/AIDS Clinical Trials Unit

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Atlanta : AIDS Research Consortium of Atlanta

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

View More »

Atlanta : Atlanta ID Group, PC

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Atlanta : Emory University

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Atlanta : Atlanta ID Group, PC

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Atlanta : AIDS Research Consortium of Atlanta

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Decatur : Infectious Disease Specialists of Atlanta

Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Decatur : Infectious Disease Specialists of Atlanta

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Decatur : Infectious Disease Specialists of Atlanta

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Decatur : Infectious Disease Specialists of Atlanta

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Decatur : Infectious Disease Specialist of Atlanta

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Decatur : Infectious Disease Specialist of Atlanta

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Macon : Mercer University School of Medicine

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Macon : Mercer University Mercer Medicine

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Macon : Mercer University School of Medicine

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Macon : Mercer University

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Savannah : Chatham County Health Daprtment

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Honolulu : University of Hawaii - Hawaii Center for AIDS

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Chicago : The Ruth M. Rothstein CORE Center

A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication

Chicago : Ruth M. Rothstein CORE Center

DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects

Chicago : NorthStar Medical Center

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Chicago : University of Chicago

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Chicago : University of Illinois at Chicago

Strategic Timing of Antiretroviral Treatment

View More »

Chicago : Lurie Children's Hospital

Strategic Timing of Antiretroviral Treatment

Chicago : Mt. Sinai Hospital

Strategic Timing of Antiretroviral Treatment

Chicago : Howard Brown Health Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Chicago : Ruth M. Rothstein CORE Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Chicago : The Ruth M. Rothstein CORE Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Chicago : Carolinas Medical Center--Myers Park Infectious Disease Clinic

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Chicago : Howard Brown Health Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Lexington : University of Kentucky Chandler Medical Center

HIV Positive Infected Patients Needed For an Observational Study of The Safety of MARAVIROC

New Orleans : LSUHSC HIV Out-Patient Clinic Research

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

New Orleans : Tulane University Medical Center

Strategic Timing of Antiretroviral Treatment

Bethesda : NIH Department of Laboratory Medicine

A Phase 2a Study of GS-6624 in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis

Bethesda : Walter Reed National Military Medical Center

Strategic Timing of Antiretroviral Treatment

Bethesda : National Institutes of Health Clinical Center

Strategic Timing of Antiretroviral Treatment

Boston : Massachusetts General Hospital

Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naïve Infected Patients

Boston : Fenway Community Health

HIV Non-Occupational Post-Exposure Prophylaxis

Boston : Community Research Initiative of New England

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Boston : Community Research Initiative of New England

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Boston : Brigham and Women's Hospital

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

View More »

Boston : Community Research Initiative of New England

Strategic Timing of Antiretroviral Treatment

Boston : Boston Medical Center

Strategic Timing of Antiretroviral Treatment

Boston : Brigham & Women's Hospital

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Boston : Community Research Initiative of New England

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Boston : Community Research Initative

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Boston : Massachusetts General Hospital

Subclinical Atherosclerosis in HIV-infected Patients

Rockland : Call EMD Serono Medical Information for information on recruiting sites

Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®

Rockland : Call EMD Serono Medical Information for information on recruiting sites

Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®

Rockland : Call EMD Serono Medical Information for Recruiting Sites

Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®

Springfield : The Research Institute

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Springfield : The Research Institute

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Springfield : The Research Institute

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

West Springfield : The Research Institute

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Berkley : Be Well Medical Center, P.C.

Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Berkley : Be Well Medical Center

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Berkley : Be Well Medical Center

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Berkley : Be Well Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Berkley : Be Well Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

View More »

Detroit : Wayne State University

Strategic Timing of Antiretroviral Treatment

Detroit : Henry Ford Health System

Strategic Timing of Antiretroviral Treatment

Detroit : Henry Ford Health System

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Detroit : Henry Ford Hospital

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

St. Louis : Central West Clinical Research Inc

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Minneapolis : MMRF, Hennepin County Medical Center

Strategic Timing of Antiretroviral Treatment

Minneapolis : Hennepin County Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Minneapolis : Hennepin County Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Rochester : Mayo Clinic

Strategic Timing of Antiretroviral Treatment

Santa Fe : Southwest CARE Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Young adults, 18 - 24 years of age, are needed for a research study.

View More »

St. Louis : Central West Clinical Research, Inc.

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

St. Louis : Washington University School of Medicine

Heart Function in HIV-Negative Children Exposed to HIV and HAART

St. Louis : Central West Clinical Research

Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

St. Louis : Central West Clinical Research

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

St. Louis : Southampton Healthcare

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

St. Louis : Central West Clinical Research, Inc.

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

St. Louis : Southampton Healthcare, Inc.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

St. Louis : St. Louis University Infectious Diseases Clinic

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

St. Louis : Southampton Healthcare, Inc.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

St. Louis : Saint Louis University

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

St. Louis : Central West Clinical Research, Inc.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Camden : Cooper University Hospital

Strategic Timing of Antiretroviral Treatment

Hillsborough : ID Care

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Hillsborough : ID Care

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Hillsborough : ID Care

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Newark : Saint Michael's Medical Center

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

View More »

Newark : New Jersey Medical School

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Newark : New Jersey Medical School Adult Clinical Research Center

Strategic Timing of Antiretroviral Treatment

Newark : Saint Michael's Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Somers Point : South Jersey Infectious Disease

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Somers Point : South Jersey Infectious Disease

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Somers Point : South Jersey Infectious Disease

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Somers Point : South Jersey Infectious Disease

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Santa Fe : Southwest CARE Center

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Santa Fe : Southwest CARE Center

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

Santa Fe : Southwest C.A.R.E. Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Bronx : Biomedical Research Alliance of New York

HIV - Adults

Bronx : Einstein-Montefiore Institute for Clinical & Translational Research

Phase I Trial Assessing the Safety and Pharmacokientics of Vaginal Tablets Containing Tenofovir and/or Emtricitabine

Manhasset : Biomedical Research Alliance of New York

Clinical trial to test how well study drug is tolerated in HIV-1 infected individuals.

Manhasset : Biomedical Research Alliance of New York

HIV - Adults

Manhasset : Biomedical Research Alliance of New York

HIV-1 Virus Infection - Adults

View More »

Albany : Upstate Infectious Diseases Associates

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Albany : Albany Medical College

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Bronx :

A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women

Bronx : Montefiore Medical Center

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Bronx : Montefiore Medical Center

Strategic Timing of Antiretroviral Treatment

Bronx : Bronx-Lebanon Hospital Center

Strategic Timing of Antiretroviral Treatment

Bronx : Jacobi Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Bronx : Montefiore Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Flushing : New York Hospital Queens

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Manhasset : North Shore University Hospital - Division of Infectious Diseases

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Manhasset : North Shore University Hospital - Division of Infectious Diseases

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Mount Vernon : Greiger Clinic

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Mount Vernon : Greiger Clinic

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

New York : Ricky K Hsu, MD, PC

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

New York : Mount Sinai School of Medicine

Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver Disease

New York : Chelsea Village Medical, PC

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

New York : Ricky K. Hsu, MD

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

New York : Ricky K Hsu, MD, PC

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

New York : New York University School of Medicine

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

New York : Cornell CRS

Strategic Timing of Antiretroviral Treatment

New York : Chelsea Village Medical

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

New York : Chelsea Village Medical

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

South Bronx : Jacobi Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Syracuse : Suny Upstate Medical University

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Chapel Hill : University of North Carolina at Chapel Hill

Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera

Chapel Hill : UNC Infectious Disease Clinic

Pharmacokinetics, Pharmacodynamics and Cervicovaginal Lavage of Combined Oral Contraceptives and Raltegravir

Chapel Hill : University of North Carolina AIDS Clinical Trials Unit

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Chapel Hill : UNC AIDS Clinical Trials Unit

Strategic Timing of Antiretroviral Treatment

Chapel Hill : The University of North Carolina - Chapel Hill

Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected ARV Naïve Patients Treated With Darunavir/Ritonavir and Etravirine

View More »

Chapel Hill : University of North Carolina AIDS Clinical Trials Unit

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Chapel Hill : University of North Carolina

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Charlotte : Carolinas Medical Center Myer's Park Clinic

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Charlotte : Infectious Disease Consultants, PA

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Charlotte : ID Consultants

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Durham : Duke University Medical Center

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Durham : Duke University Medical Center

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Durham : Duke University

Strategic Timing of Antiretroviral Treatment

Durham : Duke University

Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected ARV Naïve Patients Treated With Darunavir/Ritonavir and Etravirine

Durham : Duke University Medical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Durham : Duke University

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Greensboro : Regional Center for Infectious Disease

Strategic Timing of Antiretroviral Treatment

Huntersville : Rosedale Infectious Diseases

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Huntersville : Rosedale Infectious Diseases

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Huntersville : Rosedale Infectious Diseases

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Huntersville : Rosedale Infectious Disseases

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Raleigh : Wake County Human Services

Strategic Timing of Antiretroviral Treatment

Wilmington : Registry Coordinating Center

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.

Wilmington : GSK Investigational Site

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects

Winston-Salem : Wake Forest University Health Sciences

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Winston-Salem : Wake Forest University Health Sciences

Strategic Timing of Antiretroviral Treatment

Columbus : Wexner Medical Center at the Ohio State University

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Columbus : The Ohio State University Medical Center

Strategic Timing of Antiretroviral Treatment

Toledo : The University of Toledo Medical Center

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Portland : The Research and Education Group - Portland

Strategic Timing of Antiretroviral Treatment

Allentown : Lehigh Valley Health Network

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Philadelphia : Drexel University College of Medicine

A Study of HIV-infected Subjects Initiating Anti-HIV Drugs for the First Time

Philadelphia :

A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women

Philadelphia : Reproductive Research Unit, U of Penn Medical Center

An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots

Philadelphia : Temple General Internal Medicine

Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)

View More »

Philadelphia : Temple University Hospital- Internal General Medicine

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Philadelphia : Philadelphia FIGHT

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Philadelphia : University of Pennsylvania

Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy

Philadelphia : Temple University

Strategic Timing of Antiretroviral Treatment

Philadelphia : Thomas Jefferson University

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Philadelphia : University of Pennsylvania

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Philadelphia : University of Pennsylvania

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Pittsburgh : University of Pittsburgh

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Providence : The Miriam Hospital

A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication

Providence : The Miriam Hospital

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Providence : The Miriam Hospital

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Providence : The Miriam Hospital

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Charleston : Medical University of South Carolina

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Columbia : University of South Carolina School of Medicine

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Memphis : St. Jude Children's Research Hospital

Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Memphis : St. Jude Children's Research Hospital

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Memphis : St. Jude Children's Research Hospital

Strategic Timing of Antiretroviral Treatment

Austin : Central Texas Clinical Research

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Austin : Central Texas Clinical Research

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Austin : Central Texas Clinical Research

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Austin : Central Texas Clinical Research

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Dallas : UT Southwestern Medical Center at Dallas

HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)

View More »

Dallas : AIDS Arms, Inc./ Peabody Health Center

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Dallas : Trinity Health and Wellness Center/AIDS Arms, Inc.

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Dallas : Southwest Infectious Disease Clinical Research, Inc.

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Dallas : AIDS Arms, Inc./Trinity Health & Wellness Center

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Dallas : UT Southwestern Clinical Research Unit

Strategic Timing of Antiretroviral Treatment

Dallas : Trinity Health & Wellness Center / AIDS Arms, Inc.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Dallas : North Texas Infectious Diseases Consultants

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Dallas : Trinity Health and Wellness Center/AIDS Arms, Inc.

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Dallas : North Texas Infectious Diseases Consultants

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Dallas : UT Southwestern Medical Center

Therapeutic Approaches to HAART-Induced Lipodystrophy

Fort Worth : Tarrant County Infectious Disease Associates

Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Fort Worth : Tarrant County Infectious Disease Associates

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Fort Worth : Tarrant County Infectious Disease

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Fort Worth : University of North Texas Health Science Center

Strategic Timing of Antiretroviral Treatment

Fort Worth : Tarrant County Infectious Disease Associates

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Fort Worth : Tarrant County Infectious Disease Associates

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Houston : Therapeutic Concepts, PA

A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects

Houston : Gordon Crofoot, MD, PA

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Houston : Thomas Street Health Center-HCHD

Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy

Houston : Gordon E. Crofoot MD, PA

Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Houston : Research Access Network

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Houston : Gordon E. Crofoot MD PA

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Houston : Gordon Crofoot, MD, PA

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

Houston : Gordon Crofoot MD, PA

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Houston : Therapeutic Concepts, PA

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Houston : Texas Children's Hospital

Strategic Timing of Antiretroviral Treatment

Houston : Houston AIDS Research Team CRS

Strategic Timing of Antiretroviral Treatment

Houston : Gordon E. Crofoot, MD, PA

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Houston : Research Access Network

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Houston : Therapeutic Concepts, PA

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Houston : Gordon E. Crofoot, MD, PA

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Houston : Therapeutic Concepts, PA

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Houston : Research Access Network

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Houston : The University of Texas Health Science Center at Houston

Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)

Longview : DCOL Center for Clinical Research

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Longview : DCOL Center for Clinical Research

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Longview : DCOL Center for Clinical Research

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

San Antonio : San Antonio Military Health System

Strategic Timing of Antiretroviral Treatment

Annandale : Clinical Alliance for Research & Education, Infectious Diseases (CARE-ID)

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Annandale : Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID)

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Annandale : Clinical Alliance for Research & Education - Infectious Diseases, LLC (CARE-ID)

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Annandale : Clinical Alliance for Research & Education - Infectious Diseases (CARE-ID)

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Richmond : Virginia Commonwealth University

Strategic Timing of Antiretroviral Treatment

Seattle : University of Washington, Clinical Research Center

Levels of Raltegravir in the Female Genital Tissue

Seattle : Peter Shalit, M.D.

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Seattle : Peter Shalit, M.D.

Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Seattle : Peter Shalit, MD

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Seattle : Peter Shalit, MD

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Madison : University of Wisconsin Hospital and Clinics

A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease

Madison : University of Wisconsin Hospital and Clinics

Nelfinavir and M8 Drug-Level Monitoring in HIV-1 Infection

Milwaukee : Medical College of Wisconsin

Strategic Timing of Antiretroviral Treatment

Milwaukee : AIDS Resource Center of Wisconsin

Strategic Timing of Antiretroviral Treatment

Buenos Aires : Helios Salud

Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen

Buenos Aires : Hospital G de Agudos JM Ramos Mejia

Maraviroc Switch Collaborative Study

Buenos Aires : Hospital Italiano de Buenos Aires

Maraviroc Switch Collaborative Study

Buenos Aires : FUNCEI

Maraviroc Switch Collaborative Study

Buenos Aires : Fundacion IDEAA

Maraviroc Switch Collaborative Study

View More »

Buenos Aires : FUNCEI

Strategic Timing of Antiretroviral Treatment

Buenos Aires : Hospital General de Agudos JM Ramos Mejia

Strategic Timing of Antiretroviral Treatment

Buenos Aires : Hospital Italiano de Buenos Aires

Strategic Timing of Antiretroviral Treatment

Buenos Aires : Hospital General de Agudos Teodoro Alvarez

Strategic Timing of Antiretroviral Treatment

Buenos Aires : Fundacion IDEAA

Strategic Timing of Antiretroviral Treatment

Buenos Aires, Bs As : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Bunos Aires : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Cordoba : Hospital Rawson

Strategic Timing of Antiretroviral Treatment

El Palomar : Hospital Nacional Prof Alejandro Posadas

Maraviroc Switch Collaborative Study

El Palomar : Hospital Nacional Profesor Alejandro Posadas

Strategic Timing of Antiretroviral Treatment

Isidro Casanova : Hospital Dr Diego Paroissien

Maraviroc Switch Collaborative Study

La Matanza : Hospital Interzonal General de Agudos Dr. Diego Paroissien

Strategic Timing of Antiretroviral Treatment

La Plata : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Rosario : CAICI

Maraviroc Switch Collaborative Study

Rosario : Instituto CAICI

Strategic Timing of Antiretroviral Treatment

Adelaide : O'Brien Street Practice

Maraviroc Switch Collaborative Study

Adelaide : Royal Adelaide Hospital

Strategic Timing of Antiretroviral Treatment

Bisbane : Gladstone Road Medical Centre

Maraviroc Switch Collaborative Study

Brisbane : Brisbane Sexual Health and HIV Service (formerly AMU)

Maraviroc Switch Collaborative Study

Brisbane : Sexual Health and HIV Service - Clinic 2

Strategic Timing of Antiretroviral Treatment

View More »

Burwood : Burwood Road General Practice

Strategic Timing of Antiretroviral Treatment

Darlinghurst : Taylor Square Private Clinic

Strategic Timing of Antiretroviral Treatment

Darlinghurst : East Sydney Doctors

Strategic Timing of Antiretroviral Treatment

Darlinghurst : Holdsworth House Medical Practice

Strategic Timing of Antiretroviral Treatment

Darlinghurst : St. Vincent's Hospital

Strategic Timing of Antiretroviral Treatment

Melbourne : The Alfred Hospital

A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients

Melbourne : Alfred Hospital

Maraviroc Switch Collaborative Study

Melbourne : Royal Melbourne Hospital

Maraviroc Switch Collaborative Study

Melbourne : Monash Medical Centre

Maraviroc Switch Collaborative Study

Melbourne : Melbourne Sexual Health Centre

Strategic Timing of Antiretroviral Treatment

Melbourne : Prahran Market Clinic

Strategic Timing of Antiretroviral Treatment

Melbourne : The Alfred Hospital

Strategic Timing of Antiretroviral Treatment

Nambour : Nambour General Hospital

Maraviroc Switch Collaborative Study

Perth : Royal Perth Hospital

Strategic Timing of Antiretroviral Treatment

St Kilda : Centre Clinic

Strategic Timing of Antiretroviral Treatment

Sydney : St. Vincent's Hospital

Maraviroc Switch Collaborative Study

Sydney : Westmead Hospital

Maraviroc Switch Collaborative Study

Sydney : Holdsworth House Medical Practice

Maraviroc Switch Collaborative Study

Sydney : Royal Prince Alfred Hospital

Maraviroc Switch Collaborative Study

Sydney : Holdsworth House Medical Practice

Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.

Sydney : St Vincent Hospital, Clinical Research Program

Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.

Westmead : Westmead Hospital

Strategic Timing of Antiretroviral Treatment

Vienna : Otto-Wagner-Spital SMZ /Baumgartner Hoehe

Strategic Timing of Antiretroviral Treatment

Vienna : University Vienna General Hospital

Strategic Timing of Antiretroviral Treatment

Antwerp : Institute of Tropical Medicine

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Antwerp : Institute of Tropical Medicine

Strategic Timing of Antiretroviral Treatment

Brussels : Saint-Pierre University Hospital; Department of Infectious Diseases

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Brussels : Saint-Pierre University Hospital

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Brussels : Hôpitaux IRIS SUD

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

View More »

Brussels : Centre Hospitalier Universitaire St. Pierre (C.H.U. St. Pierre)

Strategic Timing of Antiretroviral Treatment

Ghent : Universitaire Ziekenhuizen Gent

Strategic Timing of Antiretroviral Treatment

Leuven : Universitair Ziekenhuis Gasthuisberg

Strategic Timing of Antiretroviral Treatment

Porto Alegre : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Recife : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Rio de Janeiro : Ipec/Fiocruz

Strategic Timing of Antiretroviral Treatment

Rio de Janeiro : Hospital Escola Sao Francisco de Assis - UFRJ

Strategic Timing of Antiretroviral Treatment

Salvador : SEI - Servicos Especializados em Infectologia

Strategic Timing of Antiretroviral Treatment

View More »

Sao Paolo : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Sao Paulo : Lim 56/Hcfmusp

Strategic Timing of Antiretroviral Treatment

Sao Paulo : Centro de Referencia e Treinamento DST/Aids

Strategic Timing of Antiretroviral Treatment

Sao Paulo : Instituto de Infectologia Emilio Ribas - IIER

Strategic Timing of Antiretroviral Treatment

Vitoria : Center for Infectious Diseases at the UFES

Strategic Timing of Antiretroviral Treatment

Bobo Dioulasso : Day Hospital, CHU Sanou Souro

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)

Yaounde : Day Hospital, Central Hospital

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)

Calgary : Southern Alberta Clinic

Maraviroc Switch Collaborative Study

Halifax : Victoria General

Early Versus Delayed Pneumococcal Vaccination in HIV

Hamilton : McMaster University

Early Versus Delayed Pneumococcal Vaccination in HIV

Kelowna : Medical Arts Health Research Group

Early Versus Delayed Pneumococcal Vaccination in HIV

London : St. Joseph's Hospital

Early Versus Delayed Pneumococcal Vaccination in HIV

View More »

Montreal : Montreal Chest/Royal-Victoria

Early Versus Delayed Pneumococcal Vaccination in HIV

Montreal : Clinic Opus/Lori

Maraviroc Switch Collaborative Study

Montreal : Montreal Chest Institute

Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection

Montreal : Clinique OPUS

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Montreal : Clinique Medicale L'actuel

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Montreal : Clinique medicale l'Actuel

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Ottawa : The Ottawa Hospital - General Campus

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Ottawa : The Ottawa Hospital

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Sherbrooke : Centre Hospitalier Universitaire de Sherbrooke

Early Versus Delayed Pneumococcal Vaccination in HIV

Ste-Foy : Centre Hospitalier Universitaire de Laval

Early Versus Delayed Pneumococcal Vaccination in HIV

Toronto : Sunnybrook

Early Versus Delayed Pneumococcal Vaccination in HIV

Toronto : Toronto General

Early Versus Delayed Pneumococcal Vaccination in HIV

Toronto : The Hospital for Sick Children

Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-Infected Children

Toronto : Canadian Immunodeficiency Research Collaborative (CIRC) lnc (Maple Leaf Clinic)

Maraviroc Switch Collaborative Study

Toronto : University Health Network/Toronto General Hospital

Maraviroc Switch Collaborative Study

Toronto : University Health Network - Toronto General Hospital Division

Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection

Toronto : Sunnybrook Health Science Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Toronto : Maple Leaf Research

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Toronto : Sunnybrook Health Sciences Centre

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Toronto : Maple Leaf Research

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Vancouver : St. Paul's Hospital HIV Immunodeficiency/Metabolic Clinic

Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets

Vancouver : Downtown IDC

Early Versus Delayed Pneumococcal Vaccination in HIV

Vancouver : St. Paul's Hospital

Early Versus Delayed Pneumococcal Vaccination in HIV

Vancouver : Providence Health Care- St. Paul's Hospital

Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection

Windsor : Metropolitan Hospital

Early Versus Delayed Pneumococcal Vaccination in HIV

Windsor : Moncton Hospital

Early Versus Delayed Pneumococcal Vaccination in HIV

Winnipeg : St. Boniface General Hospital

Early Versus Delayed Pneumococcal Vaccination in HIV

Winnipeg : Health Sciences Centre Winnipeg

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Winnipeg : WRHA - Health Sciences Centre Winnipeg

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Santiago : Fundación Arriarán

Maraviroc Switch Collaborative Study

Santiago : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Santiago : Fundacion Arriaran

Strategic Timing of Antiretroviral Treatment

Beijing : Division of Treatment and Care, NCAIDS, China CDC

A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance

Beijing : National Center for AIDS/STD Control and Prevention, China CDC

Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection

Plzen : University Hospital Plzen, CZ

Strategic Timing of Antiretroviral Treatment

Prague : Faculty Hospital Na Bulovce, Prague, Czech Rep.

Strategic Timing of Antiretroviral Treatment

Aarhus : Arhus Universitetshospital, Skejby

Strategic Timing of Antiretroviral Treatment

Copenhagen : Rigshospitalet, Department of Infectious Diseases, M5112 CRS

Strategic Timing of Antiretroviral Treatment

Hvidovre : Hvidovre University Hospital, Department of Infectious Diseases CRS

Strategic Timing of Antiretroviral Treatment

Odense : Odense University Hospital

Strategic Timing of Antiretroviral Treatment

Tallinn : West Tallin Central Hospital Infectious Diseases

Strategic Timing of Antiretroviral Treatment

Helsinki : Helsinki University Central Hospital, Div. of Infectious Diseases CRS

Strategic Timing of Antiretroviral Treatment

Besancon : CHU de BESANCON - Hopital Saint Jacques

Strategic Timing of Antiretroviral Treatment

Caen : CHU Cote de Nacre

Strategic Timing of Antiretroviral Treatment

Clamart : Valerie Martinez

Lenalidomide in Kaposi Disease Associated With HIV Infection

Clamart : Hopital Antoine Beclere

Strategic Timing of Antiretroviral Treatment

Creteil : Hopital Henri Mondor

Strategic Timing of Antiretroviral Treatment

View More »

Le Kremlin-Bicetre : Hopital de Bicetre

Strategic Timing of Antiretroviral Treatment

Orleans : Service Maladies infectieuses et Tropicales CHR ORLEANS La SOURCE

Maraviroc Switch Collaborative Study

Paris : Consultation d'Accueil, de Soins et d'Orientation (CASO) de Médecins du Monde (MDM)

Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests

Paris : Hopital Hotel Dieu

Strategic Timing of Antiretroviral Treatment

Paris : Hopital Europeen Georges Pompidou

Strategic Timing of Antiretroviral Treatment

Paris : Hopital Saint-Antoine

Strategic Timing of Antiretroviral Treatment

Paris : Groupe Hospitalier Pitie-Salpetriere

Strategic Timing of Antiretroviral Treatment

Paris : Hopital Saint-Louis

Strategic Timing of Antiretroviral Treatment

Suresnes : Hopital Foch

Strategic Timing of Antiretroviral Treatment

Toulon : Centre Hospitalier Intercommunal de Toulon La Seyne sur mer

IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients

Toulon : Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer, Service d'infectiologie

IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients

Tourcoing : Hopital Gustave Dron

Strategic Timing of Antiretroviral Treatment

Aachen : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Berlin : Gemeinschaftspraxis Jessen Jessen Stein

Maraviroc Switch Collaborative Study

Berlin : Dienstleistung centre ID (Baumgarten, MIB medical center for infectious diseases)

Maraviroc Switch Collaborative Study

Berlin : CHARITÉ Berlin

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Berlin : EPIMED-Gesellschaft fuer epidemiologische und klinische Forschung in der MedizinmbH

Strategic Timing of Antiretroviral Treatment

View More »

Berlin : Gemeinschaftspraxis Jessen-Jessen-Stein

Strategic Timing of Antiretroviral Treatment

Berlin : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Berlin : Charite Campus, Virchow-Klinikum Medizinische Klinik mit Schwerpunkt Infektiologie Station 59 (Suedring 11) Augustenburger Platz 1

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)

Berlin : EIPMED - Gesellschaft fűr epidemiologische und klinische Forschung in der Medizin mbH Rubensstrasse 125

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)

Bochum : University Hospital of Bochum, Department of Dermatology

Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Bonn : University of Bonn, Med J. Immunologische Siudienzenirale

Maraviroc Switch Collaborative Study

Bonn : University of Bonn

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Bonn : Medizinische Universitaetsklinik - Bonn, Immunologische Ambulanz CRS

Strategic Timing of Antiretroviral Treatment

Cologne : Klinikum der Universitat Zu Koln

Maraviroc Switch Collaborative Study

Cologne : University of Cologne

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Cologne : Klinik I fur Innere Medizin der Universitat zu Koeln, Studienbuero fuer Infektiologie u. HIV CRS

Strategic Timing of Antiretroviral Treatment

Dortmund : HIV Outpatient Department

Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Dortmund : Klinikum Dortmund gGmbH

Strategic Timing of Antiretroviral Treatment

Duesseldorf : Universitaetsklinikum Duesseldorf

Strategic Timing of Antiretroviral Treatment

Duisburg : Health Center

Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Dusseldorf : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Düsseldorf : Universitätsklinikum Düsseldorf, Klinik für Gastroenterologie, Hepatologie und Infektiologie-MX- Amb

Maraviroc Switch Collaborative Study

Erlangen : Universitaetsklinikum Erlangen

Strategic Timing of Antiretroviral Treatment

Essen : University Hospital, West German Heart Center Essen

Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Essen : University Hospital, Department of Dermatology and Venerology

Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up

Essen : Klinik fur Dermatologie, Venerologie, Allergologie

Strategic Timing of Antiretroviral Treatment

Frankfurt : Johann Wolfgang Goethe-University Hospital, Medical HIVCENTER

Maraviroc Switch Collaborative Study

Frankfurt : Johann Wolfgang Goethe - University Hospital, Infektionsambulanz CRS

Strategic Timing of Antiretroviral Treatment

Frankfurt am Main : Johann Wolfgang Goethe-Universität

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Frankfurt/Main : HIV Treatment & Research Unit, Dept. of Internal Medicine II, Hospital of the Johann Wolfgang Goethe University Frankfurt/Main

A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients

Freiburg : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Hamburg : ICH Study Center Hamburg

Maraviroc Switch Collaborative Study

Hamburg : ICH Study Center

Strategic Timing of Antiretroviral Treatment

Hamburg : University Medical Centre Hamburg-Eppendorf

Strategic Timing of Antiretroviral Treatment

Hamburg : Ifi - Studien und Projekte GmbH

Strategic Timing of Antiretroviral Treatment

Hamburg : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Hamburg : University Medical Center Hamburg-Eppendorf

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)

Hannover : Klinik für Immunologie und Rheumatologie, Medzinische Hochschule Hannover

Maraviroc Switch Collaborative Study

Hannover : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Hanover : Medizinische Hochschule Hannover

Strategic Timing of Antiretroviral Treatment

Heidelberg : Universitaetsklinikum Heidelberg

Strategic Timing of Antiretroviral Treatment

Köln : Klinik I für Innere Medizin Klinikum Der Universität zu Köln

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)

Merck Sharp & Dohme GmbH : Merck Sharp & Dohme GmbH

A Study to Assess the Efficacy of Raltegravir, Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145 AM1) (Wirksamkeit Von Isentress® Unter Praxisbedingungen)

Munchen : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

München : University München

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Munich : Klinikum der Universitaet Muenchen

Strategic Timing of Antiretroviral Treatment

Regensburg : Universitaetsklinikum Regensburg

Strategic Timing of Antiretroviral Treatment

Regensburg : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Stuttgart : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Wuerzburg : University of Wuerzburg, Medizinische Poliklinik, Schwerpunkt Hepatologie/Infektologie CRS

Strategic Timing of Antiretroviral Treatment

Athens : Hippokration University General Hospital of Athens

Strategic Timing of Antiretroviral Treatment

Athens : Evangelismos General Hospital

Strategic Timing of Antiretroviral Treatment

Athens : Syngros Hospital

Strategic Timing of Antiretroviral Treatment

Athens : Attikon University General Hospital

Strategic Timing of Antiretroviral Treatment

Athens : Korgialenio-Benakio Hellenic Red Cross

Strategic Timing of Antiretroviral Treatment

View More »

Thessaloniki : AHEPA University Hospital

Strategic Timing of Antiretroviral Treatment

Dublin : Mater Misericordiae University Hospital

Maraviroc Switch Collaborative Study

Dublin : St James's Hospital Dublin

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Dublin : Mater Hospital and UCD

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Dublin : Mater Misericordiae University Hospital

Strategic Timing of Antiretroviral Treatment

Haifa : Rambam Medical Center

Strategic Timing of Antiretroviral Treatment

Tel Aviv : Tel Aviv Sourasky Medical Center

Strategic Timing of Antiretroviral Treatment

Milan : Ospedale San Raffaele S.r.l.

Strategic Timing of Antiretroviral Treatment

Modena : Policlinico di Modena, Divisione di Malattie Infettive

A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)

Monza : Azienda Ospedaliera San Gerardo, Divisione di Malattie Infettive

A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)

Rome : IFO - S. Gallicano, Dermatologia Infettiva

A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)

Rome : IRCSS

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

View More »

Rome : Lazzaro Spallanzani IRCSS

Strategic Timing of Antiretroviral Treatment

Varese : Ospedale di Circolo and Fondazione Macchi

Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients

Nagoya : Nagoya Medical Center

Maraviroc Switch Collaborative Study

Shinjuku-ku, Tokyo : National Center for Global Health and Medicine AIDS Clinical Center

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

Luxembourg : Centre Hospitalier de Luxembourg

Strategic Timing of Antiretroviral Treatment

Kuala Lumpur : University Malaya Medical Centre

Strategic Timing of Antiretroviral Treatment

Bamako : Serefo/Cesac Mali

Strategic Timing of Antiretroviral Treatment

Df : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Guadalajara : Hospital Civil de Guadalajara

Maraviroc Switch Collaborative Study

Guadalajara : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Leon : Hospital General de Leon

Maraviroc Switch Collaborative Study

Merida : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

View More »

Mexico City : INCMNSZ

Maraviroc Switch Collaborative Study

Oaxaca : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Tlalpan : INCMNSZ

Strategic Timing of Antiretroviral Treatment

Casablanca : University Hospital Centre Ibn Rochd

Strategic Timing of Antiretroviral Treatment

Nijmegen : CRCN Radboud University Nijmegen Medical Centre

Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.

Nijmegen : Radboud University Nijmegen Medical Centre

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Rotterdam : Erasmus Medical Center Rotterdam

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Abuja : Institute of Human Virology-Nigeria (IHVN)

Strategic Timing of Antiretroviral Treatment

Oslo : Oslo University Hospital, Ulleval

Strategic Timing of Antiretroviral Treatment

Lima : Asociacion Civil Impacta Salud y Educacion

Strategic Timing of Antiretroviral Treatment

Lima : IMPACTA San Miguel

Strategic Timing of Antiretroviral Treatment

Lima : Via Libre

Strategic Timing of Antiretroviral Treatment

Lima : Hospital Nacional Guillermo Almenara Irigoyen

Strategic Timing of Antiretroviral Treatment

Lima : Hospital Nacional Edgardo Rebagliati Martins

Strategic Timing of Antiretroviral Treatment

Bialystok : Wojewodzki Szpital Specjalistyczny

Strategic Timing of Antiretroviral Treatment

Warsaw : Wojewodzki Szpital Zakazny

Strategic Timing of Antiretroviral Treatment

Warszawa : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Wroclaw : EMC Instytut Medyczny SA

Strategic Timing of Antiretroviral Treatment

Aveiro : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Barreiro : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Lisboa : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Lisbon : Hospital de Santa Maria

Strategic Timing of Antiretroviral Treatment

Lisbon : Hospital de Egas Moniz

Strategic Timing of Antiretroviral Treatment

View More »

Lisbon : Hospital Curry Cabral

Strategic Timing of Antiretroviral Treatment

Oporto : Hospital Joaquim Urbano

Strategic Timing of Antiretroviral Treatment

Porto : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Pragal : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Santarem : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Sao Martinho do Bispo : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Vila Nova de Gaia : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Rio Piedras : San Juan Hospital

Strategic Timing of Antiretroviral Treatment

San Juan : Clinical Research Puerto Rico

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

San Juan : HOPE Clinical Research

Open-label Safety Study of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

San Juan : Maternal Infants Studies Center (CEMI)

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

San Juan : University of Puerto Rico Pediatric Research Site

Strategic Timing of Antiretroviral Treatment

View More »

San Juan : Puerto Rico-AIDS Clinical Trials Unit (PR-ACTU)

Strategic Timing of Antiretroviral Treatment

San Juan : HOPE Clinical Research

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

San Juan : Hope Clinical Research

Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults

San Juan Pr :

A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women

Bucharest : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Moscow : Federal scientific and methodological center on AIDS prophylaxis and control

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

Moscow : Moscow regional center on AIDS and infectious diseases prophylaxis and control

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

Nizhnij Novgorod : Regional Center on AIDS and Infectious Diseases Prophylaxis and Control

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

Saint-Petersburg : Saint-Petersburg Center on AIDS and Infectious Diseases Prophylaxis and Control

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

Saint-Petersburg : Federal State Institution Republican clinical infectious hospital of Roszdrav

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

View More »

Smolensk : Smolensk Center on AIDS and infectious diseases prophylaxis and control

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

Smolensk : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

St. Petersburg : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

St.petersburg : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Dakar : Clinical Research and Training Center, Fann Hospital

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)

Benoni : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Bloemfontein : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Bloemfontein :

TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents

Cape Town : Desmond Tutu HIV Research Centre

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Cape Town : Desmond Tutu HIV Foundation Clinical Trials Unit

Strategic Timing of Antiretroviral Treatment

View More »

Dundee : Mpati Medical Center

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Durban : South African MRC HIV CTU Med Research Council; Tongaat

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Durban : South African MRC HIV CTU Med Research Council; Umkomaas

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Durban : South African MRC HIV CTU Med Research Council; Botha's Hill Clinical Research Site

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Durban : South African MRC HIV CTU Med Research Council; Overport

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Durban : South African MRC HIV CTU Med Research Council; Verulam

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Durban : South African MRC HIV CTU Med Research Council; R.K. Khan Hospital

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Durban : South African MRC HIV CTU Med Research Council; Isipingo

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Durban : CAPRISA eThekwini

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Durban : CAPRISA eThekwini Clinical Research Site

Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services

Durban : University KZN

Strategic Timing of Antiretroviral Treatment

Durban : DICTU

Strategic Timing of Antiretroviral Treatment

Durbanville : Tygerberg Hospital, Inf. Dis.

Preparedness Study - HPV Vaccine

Gauteng : Perinatal HIV Research Unit

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Johannesburg : Perinatal HIV Research Unit (PHRU)

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Johannesburg : Wits Reproductive Health Institute (WRHI)

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Johannesburg : CAPRISA-The Aurum Institute

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Johannesburg : Clinical HIV Research Unit

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Johannesburg : CHRU

Strategic Timing of Antiretroviral Treatment

Johannesburg :

TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents

Newtown :

TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents

Parow : Stellenbosch University

Preparedness Study - HPV Vaccine

Parrow Valley : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Pietermaritzburg : CAPRISA Vulindlela Clinical Research Site

Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services

Port Elizabeth : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Pretoria : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Pretoria : 1 Military Hospital

Strategic Timing of Antiretroviral Treatment

Pretoria N/A :

TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents

Soweto : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Alcala de Henares : Hospital Universitario Principe de Asturias

Strategic Timing of Antiretroviral Treatment

Alcalá de Henares : Hospital Príncipe de Asturias

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Alcalá de Henares : Hospital Príncipe de Asturias

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Alicante : Hospital General de Alicante

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Asturias : H. Universitario Central de Asturias

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

View More »

Badalona : Hospital Germans Trias i Pujol

Maraviroc Switch Collaborative Study

Badalona : Hospital Universitari Germans Trias i Pujol, Badalona

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Badalona : H. Germans Trias i Pujol

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Badalona : Hospital Universitari Germans Trias I Pujol, HIV Unit and Retrovirology Lab CRS

Strategic Timing of Antiretroviral Treatment

Badalona : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Barcelona : Hospital de la Santa Creu i Sant Pau

Maraviroc Switch Collaborative Study

Barcelona : Hospital Clínic de Barcelona

Maraviroc Switch Collaborative Study

Barcelona : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Barcelona : Hospital Vall d'Hebrón

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Barcelona : Hospital Santa Creu i Sant Pau

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Barcelona : Hospital del Mar

Strategic Timing of Antiretroviral Treatment

Barcelona : Hospital de la Santa Creu i Sant Pau

Strategic Timing of Antiretroviral Treatment

Barcelona : Hospital Clinico de Barcelona CRS

Strategic Timing of Antiretroviral Treatment

Barcelona : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Basurto : Hospital de Basurto

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Córdoba : Hospital Reina Sofía

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

El Ferrol : Hospital Arquitecto Marcide

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Elche : Hospital de Elche

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Granada : Hospital Universitario Virgen de las Nieves Granada; Médico Adjunto del Servicio de Medicina Interna

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

Granada : Hospital Clínico San Cecilio

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Granada : Hospital Virgen de las Nieves

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Granada : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Granollers : Hospital General de Granollers

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Granollers : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Guadalajara : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Huelva : H. Juan Ramón Jiménez

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Jerez de la Frontera : Hospital de Jerez

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Jerez de la Frontera : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

La Coruña : Hospital Juan Canalejo

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Leganes : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Leganés : Hospital Severo Ochoa

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Logrono : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Logroño : H. San Pedro

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Madrid : Hospital Gregorio Marañón

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Madrid : Hospital Ramón y Cajal

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Madrid : Hospital Doce de Octubre

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Madrid : Hospital Clínico San Carlos

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Madrid : Hospital La Paz

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Madrid : Hospital La Paz,

Maraviroc Switch Collaborative Study

Madrid : Hospital Principe de Asturias

Maraviroc Switch Collaborative Study

Madrid : Hospital General Universitario Gregorio Marañón (HGUGM)

Maraviroc Switch Collaborative Study

Madrid : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Madrid : Hospital La Paz

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Madrid : H. Universitario Infanta Leonor

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Madrid : H. Clinico San Carlos

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Madrid : Hospital Doce de Octubre

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Madrid : Hospital Gregorio Marañón

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Madrid : Hospital Ramón y Cajal

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Madrid : Hospital La Princesa, Internal Medicine and Infectious Disease Service CRS

Strategic Timing of Antiretroviral Treatment

Madrid : Hospital La Paz

Strategic Timing of Antiretroviral Treatment

Madrid : Hospital Clinico San Carlos

Strategic Timing of Antiretroviral Treatment

Madrid : Hospital Universitario Doce de Octubre

Strategic Timing of Antiretroviral Treatment

Madrid : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Malaga : Hospital Regional Carlos Haya de Málaga

Maraviroc Switch Collaborative Study

Malaga : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Málaga : Hospital Virgen de la Victoria

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Mallorca : H. Universitario Son Espases

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Marbella : Hospital Costa del Sol

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Marbella : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Mataro : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Mataró : Hospital de Mataró

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Mostoles : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Pamplona : Hospital de Navarra

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

San Sebastián : Hospital Donostia

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Santander : Hospital Marqués de Valdecilla

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Santiago de Compostela : Complexo Hospitalario Universitario de Santiago

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Santiago de Compostela : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Sevilla : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Tarragona : Hospital de Santa Tecla

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Tarragona : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Terrassa : Hospital Universitari Mutua Terrassa

Strategic Timing of Antiretroviral Treatment

Valencia : Hospital Universitari i Politecnic La Fe

Maraviroc Switch Collaborative Study

Valencia : Hospital Clínico Universitario de valencia

Maraviroc Switch Collaborative Study

Valencia : Hospital La Fe

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Valencia : Hospital General Universitario de Valencia

Strategic Timing of Antiretroviral Treatment

Valencia : Hospital Universitario y Politecnico La Fe

Strategic Timing of Antiretroviral Treatment

Valencia : Local Institution

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Vigo : Hospital Xeral Cíes

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Vigo : Complejo Hospitalario Xeral Cies

Strategic Timing of Antiretroviral Treatment

Villajoyosa : Hospital Marina Baixa

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Gothenburg : Sahlgrenska University Hospital

Strategic Timing of Antiretroviral Treatment

Malmo : Skane University Hospital

Strategic Timing of Antiretroviral Treatment

Basel : University Hospital Basel

Strategic Timing of Antiretroviral Treatment

Bern : Bern University Hospital

Strategic Timing of Antiretroviral Treatment

Geneva : Unite VIH/SIDA Geneva

Strategic Timing of Antiretroviral Treatment

Zurich : University Hospital Zurich

Raltegravir in the Swiss HIV Cohort Study

Zurich : University Hospital Zurich

Strategic Timing of Antiretroviral Treatment

Bangkok : The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT)

Abacavir and Lamivudine PK in Children

Bangkok : Chulalongkorn University Hospital

Maraviroc Switch Collaborative Study

Bangkok : The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT)

Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents

Bangkok : Chulalongkorn University Hospital

Strategic Timing of Antiretroviral Treatment

Bangkok : Ramathibodi Hospital

Strategic Timing of Antiretroviral Treatment

View More »

Bangkok Noi : Siriraj Hospital

Strategic Timing of Antiretroviral Treatment

Chiang Mai : Sanpatong Hospital

Strategic Timing of Antiretroviral Treatment

Chiang Mai : Research Institute for Health Sciences (RIHES)

Strategic Timing of Antiretroviral Treatment

Chiangrai : Chiangrai Prachanukroh Hospital

Strategic Timing of Antiretroviral Treatment

Chonburi : Chonburi Regional Hospital

Strategic Timing of Antiretroviral Treatment

Khon Kaen : Khon Kaen University, Srinagarind Hospital

Strategic Timing of Antiretroviral Treatment

Nonthaburi : Bamrasnaradura Institute

Strategic Timing of Antiretroviral Treatment

Entebbe : MRC UVRI Uganda Research Unit on AIDS

Strategic Timing of Antiretroviral Treatment

Fort Portal : JCRC Fort Portal

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Gulu : JCRC Gulu

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Kabale : JCRC Kabale

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Kakira : JCRC Kakira

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

View More »

Kampala : San Raphael of St Francis Hospital, Nsambya

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Kampala : JCRC Kampala

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Kampala : Infectious Diseases Institute (IDI)

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Kampala : Makerere University-Johns Hopkins University Collaboration

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Kampala : Joint Clinical Research Center (JCRC)

Strategic Timing of Antiretroviral Treatment

Mbale : JCRC Mbale

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Mbarara : JCRC Mbarara

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Mbarara region : Southwestern Uganda

Sustainable East Africa Research in Community Health

Belfast : Belfast Health and Social Care Trust (RVH)

Strategic Timing of Antiretroviral Treatment

Birmingham : Local Institution

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Birmingham : Queen Elizabeth Hospital Birmingham

Strategic Timing of Antiretroviral Treatment

Birmingham : Birmingham Heartlands Hospital

Strategic Timing of Antiretroviral Treatment

Bournemouth : Royal Bournemouth Hospital

Strategic Timing of Antiretroviral Treatment

View More »

Brighton : Brighton & Sussex University NHS Trust

Maraviroc Switch Collaborative Study

Brighton : Brighton and Sussex University Hospitals NHS Trust

Strategic Timing of Antiretroviral Treatment

Chertsey : Ashford and St Peter's Hospitals NHS Foundation Trust

Maraviroc Switch Collaborative Study

Coventry : Coventry and Warwickshire NHS partnership Trust

Strategic Timing of Antiretroviral Treatment

Gloucester : Gloucestershire Royal Hospital

Strategic Timing of Antiretroviral Treatment

Guildford : Surrey Clinical Research Centre University of Surrey

EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine

Leicester : Leicester Royal Infirmary

Strategic Timing of Antiretroviral Treatment

London : St Marys Hospital NHS Trust

A Prospective, Observational Study to Examine the Effects of Ageing on the 'Pharmacokinetic and Clinical Observations in People Over Fifty'

London : Chelsea and Westminster Hospital

Maraviroc Switch Collaborative Study

London : St. Mary's Hospital, Imperial College

Maraviroc Switch Collaborative Study

London : Barts Healthcare

Maraviroc Switch Collaborative Study

London : C&W Hospital, London

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

London : St Mary's Hospital, London

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

London : St. George's Hospital, London

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

London : Kings College London

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

London : Barts Healthe NHS Trust

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

London : Homerton University Hospital NHS Foundation Trust

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

London : Royal Free London NHS Foundation Trust

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

London : Barts Health NHS Trust

Strategic Timing of Antiretroviral Treatment

London : Imperial College Healthcare NHS Trust

Strategic Timing of Antiretroviral Treatment

London : St. George's Healthcare NHS Trust

Strategic Timing of Antiretroviral Treatment

London : Guy's and St.Thomas' NHS Foundation Trust

Strategic Timing of Antiretroviral Treatment

London : Royal Free London NHS Foundation Trust

Strategic Timing of Antiretroviral Treatment

London : South London Healthcare NHS Trust

Strategic Timing of Antiretroviral Treatment

London : University College London Medical School

Strategic Timing of Antiretroviral Treatment

London : Chelsea and Westminster Hospital

Strategic Timing of Antiretroviral Treatment

London : Imperial College Healthcare NHS Trust

The Rilpivirine Cerebrospinal-fluid (CSF) Study

Manchester : North Manchester General Hospital

Strategic Timing of Antiretroviral Treatment

Middlesbrough : The James Cook University Hospital

Strategic Timing of Antiretroviral Treatment

Reading : Royal Berkshire Hospital

Strategic Timing of Antiretroviral Treatment

Sheffield : Sheffield Teaching Hospital NHS Foundation Trust

Strategic Timing of Antiretroviral Treatment

Chitungwiza : UZ-UCSF HIV Prevention Trials Unit

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Chitungwiza : UZ-UCSF HIV Prevention Trials Unit

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)

Harare : UZ-UCSF HIV Prevention Trials Unit

EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)